The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
